Cargando…
The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer’s disease
An impairment of amyloid β-peptide (Aβ) clearance is suggested to play a key role in the pathogenesis of sporadic Alzheimer’s disease (AD). Amyloid degradation is mediated by various mechanisms including fragmentation by enzymes like neprilysin, matrix metalloproteinases (MMPs) and a recently identi...
Autores principales: | Kirabali, Tunahan, Rigotti, Serena, Siccoli, Alessandro, Liebsch, Filip, Shobo, Adeola, Hock, Christoph, Nitsch, Roger M., Multhaup, Gerhard, Kulic, Luka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892233/ https://www.ncbi.nlm.nih.gov/pubmed/31796114 http://dx.doi.org/10.1186/s40478-019-0846-8 |
Ejemplares similares
-
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression
por: Liebsch, Filip, et al.
Publicado: (2019) -
Mechanisms of amyloid-β34 generation indicate a pivotal role for BACE1 in amyloid homeostasis
por: Ulku, Irem, et al.
Publicado: (2023) -
iPS‐derived pericytes for neurovascular regeneration
por: Kirabali, Tunahan, et al.
Publicado: (2021) -
Familial Alzheimer’s disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system
por: Tackenberg, Christian, et al.
Publicado: (2020) -
Chronic Intranasal Treatment with an Anti-Aβ(30-42) scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
por: Cattepoel, Susann, et al.
Publicado: (2011)